Mostrar registro simples

dc.contributor.authorCatelli, Dayenne Helenapt_BR
dc.contributor.authorPortich, Julia Plentzpt_BR
dc.contributor.authorCalvache, Ebellins Tabarespt_BR
dc.contributor.authorWeber, Cristiane Seganfredopt_BR
dc.contributor.authorHoffmann, Daniel Sanderpt_BR
dc.contributor.authorBosi, Guilherme Rasiapt_BR
dc.contributor.authorSekine, Leopt_BR
dc.contributor.authorSilla, Lucia Mariano da Rochapt_BR
dc.date.accessioned2024-01-09T03:36:31Zpt_BR
dc.date.issued2023pt_BR
dc.identifier.issn2357-9730pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/270744pt_BR
dc.description.abstractThe history of hemophilia is ancient, with descriptions dated to the 2nd century AD. The first modern narratives appeared in 1800s, when total blood transfusion was the only available treatment and life expectancy was remarkably low. Advances occurred with the use of plasma and cryoprecipitate, but only the discovered of factor concentrates revolutionized the treatment. The implantation of prophylaxis allowed hemophilic patients to prevent bleeding and the development of chronic arthropathy, although with a significant burdensome with the regular infusions. In the past 20 years, this field has witnessed major improvements, including the development of gene therapy and other pharmacological approaches.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofClinical and biomedical research. Porto Alegre. Vol. 43, no. 1 (2023), p. 69-74pt_BR
dc.rightsOpen Accessen
dc.subjectHemofilia Apt_BR
dc.subjectHemophilia Aen
dc.subjectHemophilia Ben
dc.subjectHemofilia Bpt_BR
dc.subjectBiographyen
dc.subjectFator VIIIpt_BR
dc.subjectFator IXpt_BR
dc.subjectHistóriapt_BR
dc.titleHemophilia : a biography on therapeutical approachespt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001187396pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples